Results 61 to 70 of about 499,568 (198)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo [PDF]

open access: yes, 2017
Infections with hepatitis C virus (HCV) represent a worldwide health burden and a prophylactic vaccine is still not available. Liver transplantation (LT) is often the only option for patients with HCV-induced end-stage liver disease. However, immediately
Ahmed Atef Mesalam   +63 more
core   +6 more sources

Liver Disease as a Predictor of New‐Onset Atrial Fibrillation

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Impact of liver disease on development of atrial fibrillation (AF) is unclear. The purpose of the study was to evaluate prevalence of AF in the setting of liver disease and whether increasing severity of liver disease, using Model for End ...
William A. Huang   +3 more
doaj   +1 more source

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites [PDF]

open access: yesClinical and Molecular Hepatology, 2014
Background/AimsThe modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in 2011.
Jun Jae Kim   +6 more
doaj   +1 more source

Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation [PDF]

open access: yes, 2016
Background Liver transplantation is the optimal treatment option for end-stage liver disease, but organ shortages dramatically restrict its application. Donation after cardiac death (DCD) is an alternative approach that may expand the donor pool, but it ...
Haiyang Xie   +9 more
core   +3 more sources

Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients

open access: yesClinics, 2015
OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treatment, increasing deaths among those on the waiting list.
Elisa Maria de Camargo Aranzana   +5 more
doaj   +1 more source

Important predictor of mortality in patients with end-stage liver disease [PDF]

open access: yesClinical and Molecular Hepatology, 2013
Prognosis is an essential part of the baseline assessment of any disease. For predicting prognosis of end-stage liver disease, many prognostic models were proposed.
Hyung Joon Kim, Hyun Woong Lee
doaj   +1 more source

Frailty and the Burden of Concurrent and Incident Disability in Patients With Cirrhosis: A Prospective Cohort Study. [PDF]

open access: yes, 2020
Frailty results from the chronic effects of malnutrition and muscle wasting in patients with cirrhosis. It is well-established that frailty is strongly associated with mortality in this population.
Covinsky, Kenneth E   +4 more
core   +2 more sources

Compressive stenosis of the left hepatic vein as a pathogenesis of postresectional liver failure: a case report [PDF]

open access: yes, 2010
Introduction Postresectional liver failure (PLF) is a devastating and fatal complication of major hepatic resection, and we do not have a full understanding of the pathogenic mechanisms involved.
Mizuki Ninomiya   +14 more
core   +2 more sources

Simple new risk score model for adult cardiac extracorporeal membrane oxygenation: simple cardiac ECMO score. [PDF]

open access: yes, 2015
BACKGROUND: Although the use of cardiac extracorporeal membrane oxygenation (ECMO) is increasing in adult patients, the field lacks understanding of associated risk factors. While standard intensive care unit risk scores such as SAPS II (simplified acute
Cavarocchi, Nicholas   +3 more
core   +2 more sources

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation [PDF]

open access: yes, 2015
BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis in chronic liver disease; however, it is invasive, with the potential for serious complications.
  +503 more
core   +2 more sources

Home - About - Disclaimer - Privacy